Urology · Denver, CO
NPI
1558300483
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2777 Mile High Stadium Cir
Denver, CO, 80211
Phone (303) 825-8822
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
2,560 services
Medicare patients, 2024
142
Average age 77
Drug cost, 2024
$5.4M
1,505 prescriptions
Company payments, 2024
$749
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen R Ruyle was code J9217 (leuprolide acetate (for depot suspension), 7.5 mg), 316 times for 56 patients. In total Stephen R Ruyle billed 2,560 services in 38 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 316 | 56 | $135.17 | $43K |
| 99214 Office E&M - Established | Office | 81 | 75 | $65.04 | $5,268 |
| 96402 Chemotherapy Administration | Office | 63 | 58 | $28.61 | $1,803 |
| 99213 Office E&M - Established | Office | 35 | 35 | $53.34 | $1,867 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 32 | 24 | $27.96 | $895 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 15 | $12.10 | $182 |
By year: 2022 $297K for 11,352 services; 2023 $366K for 12,018 services; 2024 $71K for 2,560 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 698 | 428 | $8.40 | $5,863 |
| 81003 Clinical Chemistry | 655 | 474 | $2.20 | $1,439 |
| 84153 Clinical Chemistry | 419 | 296 | $17.98 | $7,532 |
| 87798 Infectious Agent Detection by DNA/RNA | 273 | 19 | $34.39 | $9,388 |
| 84403 Clinical Chemistry | 168 | 91 | $25.29 | $4,249 |
| 87481 Infectious Agent Detection by DNA/RNA | 105 | 19 | $34.39 | $3,611 |
| 84154 Clinical Chemistry | 68 | 56 | $17.76 | $1,207 |
| 86316 Immunoassay | 65 | 53 | $20.13 | $1,309 |
| 87640 Infectious Agent Detection by DNA/RNA | 21 | 19 | $34.39 | $722 |
| 87651 Infectious Agent Detection by DNA/RNA | 21 | 19 | $34.39 | $722 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen R Ruyle prescribed most often to Medicare patients was Tamsulosin Hcl, with 263 prescriptions and refills. In total Stephen R Ruyle wrote 1,505 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 263 | 739 | 101 | $3,773 |
| Orgovyx Relugolix | 212 | 212 | 37 | $563K |
| Nubeqa Darolutamide | 196 | 196 | 28 | $2.7M |
| Abiraterone Acetate Generic | 166 | 176 | 26 | $67K |
| Prednisone Generic | 152 | 200 | 28 | $627 |
| Finasteride Generic | 136 | 396 | 53 | $1,645 |
| Erleada Apalutamide | 67 | 73 | Under 11 | $1.0M |
| Xtandi Enzalutamide | 64 | 70 | 11 | $983K |
| Dutasteride Generic | 53 | 155 | 21 | $1,517 |
| Myrbetriq Mirabegron | 37 | 90 | 13 | $41K |
| Solifenacin Succinate Generic | 24 | 72 | Under 11 | $1,015 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 16 | 50 | Under 11 | $571 |
| Alendronate Sodium Generic | 12 | 36 | Under 11 | $55.6 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 12 | 26 | Under 11 | $174 |
| Oxybutynin Chloride Generic | 11 | 13 | Under 11 | $161 |
Brand drugs: - claims; generic drugs: 914 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Stephen R Ruyle $749 ($749 in general payments such as food, travel and fees) from 13 companies. The largest payer was Janssen Biotech, Inc. with $296.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 4 | $296 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $82.55 |
| Abbvie Inc. ABBV | 3 | $64.01 |
| Pfizer Inc. PFE | 3 | $52.94 |
| Progenics Pharmaceuticals, Inc. | 2 | $51.76 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $31.98 |
| Tempus AI, Inc TEM | 1 | $27.94 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $26.75 |
| Astellas Pharma US Inc 4503.T | 1 | $25.88 |
| Boston Scientific Corporation BSX | 1 | $25.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.